Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) posted its quarterly earnings data on Wednesday. Nurix Therapeutics had a negative return on equity of 53.57% and a negative net margin of 292.50%. Nurix Therapeutics has a 12-month low of $8.18 and a 12-month high of $22.50. Get Nurix Therapeutics alerts:Insiders Place Their BetsIn related news, CFO Houte Hans Van sold 6,284 shares of Nurix Therapeutics stock in a transaction on Monday, November 3rd. Read MoreReceive News & Ratings for Nurix Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nurix Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.